Fox Business: Hims & Hers responds to FDA pressure, pulls knockoff Wegovy drug launch after regulatory threats Hims & Hers responds to FDA pressure, pulls knockoff Wegovy drug launch after regulatory threats After receiving FDA approval in December 2025, Danish pharmaceutical company Novo Nordisk is rolling out a pill version of their popular Wegovy weight loss drug in January 2026. Senior Correspondent ... Wegovy® (semaglutide) injection 2.4 mg or tablets 25 mg for adults with obesity.

Context Explanation

See how Wegovy® supports weight loss with guidance, dosing information and savings resources to help you get started. Read important safety and prescribing info, including boxed warning. Wegovy® (semaglutide) injection 2.4 mg or tablets 25 mg. Learn how to use the Wegovy® pen with dosing schedule, storage information and tips for success with the once-weekly Wegovy® pen.

Insight Material

Read important safety and prescribing info, including boxed warning. Wegovy ® (semaglutide) injection and Wegovy ® (semaglutide) tablets are prescription medicines used with a reduced calorie diet and increased physical activity to: reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight. help adults with obesity, or some adults with excess weight ... Wegovy®, along with a reduced-calorie diet and increased physical activity, is a prescription medicine used to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with known heart disease and with either obesity or overweight. Wegovy® (semaglutide) injection 2.4 mg or tablets 25 mg.

Final Conclusion

Learn how to get Wegovy® to support your weight loss journey and see the steps to talk to your doctor, confirm eligibility and move toward a prescription. Read important safety and prescribing info, including boxed warning.